David Fyfield quoted in Pharmaceutical Journal and MedicalHealthNews on the impact of the pregabalin case for second medical use patents
David Fyfield has been quoted in Pharmaceutical Journal and MedicalHealthNews on the impact of the pregabalin case for second medical use patents.